Cargando…

Scar heterogeneity on cardiovascular magnetic resonance as a predictor of appropriate implantable cardioverter defibrillator therapy

BACKGROUND: Despite the survival benefit of implantable-cardioverter-defibrillators (ICDs), the vast majority of patients receiving an ICD for primary prevention do not receive ICD therapy. We sought to assess the role of heterogeneous scar area (HSA) identified by late gadolinium enhancement cardio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rayatzadeh, Hussein, Tan, Alex, Chan, Raymond H, Patel, Shalin J, Hauser, Thomas H, Ngo, Long, Shaw, Jaime L, Hong, Susie N, Zimetbaum, Peter, Buxton, Alfred E, Josephson, Mark E, Manning, Warren J, Nezafat, Reza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3750752/ https://www.ncbi.nlm.nih.gov/pubmed/23574733 http://dx.doi.org/10.1186/1532-429X-15-31

Ejemplares similares

Subcutaneous Implantable Cardioverter-Defibrillator Shock: Appropriate or Inappropriate?
por: Ip, James E.
Publicado: (2017)

An appropriate shock of the wearable cardioverter-defibrillator in an outpatient setting
por: Kishihara, Jun, et al.
Publicado: (2016)

Predictors of appropriate ICD therapy in patients with implantable cardioverter-defibrillator
por: Dehghani, Mohammad Reza, et al.
Publicado: (2006)

Baseline and Dynamic Risk Predictors of Appropriate Implantable Cardioverter Defibrillator Therapy
por: Wu, Katherine C., et al.
Publicado: (2020)

Improved late gadolinium enhancement imaging of left ventricle with isotropic spatial resolution
por: Akcakaya, Mehmet, et al.
Publicado: (2012)

Left Atrial scar assessment using imaging with isotropic spatial resolution and compressed sensing
por: Akcakaya, Mehmet, et al.
Publicado: (2012)

Incidence of appropriate cardioverter-defibrillator shocks and mortality in patients with implantable cardioverter-defibrillators with ischemic cardiomyopathy versus nonischemic cardiomyopathy at 33-month follow-up
por: Gandhi, Kaushang, et al.
Publicado: (2010)

Fragmented QRS as a Predictor of Appropriate Implantable Cardioverter-defibrillator Therapy
por: Apiyasawat, Sirin, et al.
Publicado: (2014)

Dutch outcome in implantable cardioverter-defibrillator therapy (DO-IT): registry design and baseline characteristics of a prospective observational cohort study to predict appropriate indication for implantable cardioverter-defibrillator
por: van Barreveld, M., et al.
Publicado: (2017)

Improved fat water separation with water selective inversion pulse for inversion recovery-based cardiac MRI sequence
por: Havla, Lukas, et al.
Publicado: (2012)

Appropriateness of Prescription and Safety of Wearable Cardioverter Defibrillators: A Single-center Experience
por: Sundhu, Murtaza, et al.
Publicado: (2019)

Appropriate therapy for implantable cardioverter defibrillators used as primary versus secondary prophylaxis
por: Thuraiaiyah, J, et al.
Publicado: (2023)

Paradox of Appropriate Implantable Cardioverter‐Defibrillator Therapy: Saving Lives But Revealing an Increased Mortality Risk
por: Aleong, Ryan G., et al.
Publicado: (2017)

Myocardial Scar Characterization and Future Ventricular Arrhythmia in Patients With Ischemic Cardiomyopathy and an Implantable Cardioverter-Defibrillator
por: Noordman, Alwin B. P., et al.
Publicado: (2021)

Implantable cardioverter-defibrillators /
Publicado: (1994)

Implantable cardioverter-defibrillators in congenital heart disease
por: Chubb, H., et al.
Publicado: (2016)

Appropriate Implantable Cardioverter-Defibrillator Therapies Delivered 5 Years After End of Service
por: Yuyun, Matthew F., et al.
Publicado: (2020)

Feasibility of real time integration of high-resolution scar images with invasive electrograms in electro-anatomical mapping system in patients undergoing ventricular tachycardia ablation
por: Roujol, Sébastien, et al.
Publicado: (2013)

Free-breathing late gadolinium enhancement CMR with a fixed short scan time using CosMo
por: Moghari, Mehdi H, et al.
Publicado: (2012)

BAYESIAN META-ANALYSIS ON MEDICAL DEVICES: APPLICATION TO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
por: Youn, Ji-Hee, et al.
Publicado: (2012)

Ventricular tachycardia as presenting arrhythmia as a determinant of appropriate implantable cardioverter-defibrillator therapy in secondary prevention
por: Noordman, A B P, et al.
Publicado: (2023)

Mortality and predictors of appropriate implantable cardioverter defibrillator therapy in Japanese patients with Multicenter Automatic Defibrillator Implantation Trial II criteria
por: An, Yoshimori, et al.
Publicado: (2017)

Dutch Outcome in Implantable Cardioverter‐Defibrillator Therapy: Implantable Cardioverter‐Defibrillator–Related Complications in a Contemporary Primary Prevention Cohort
por: van Barreveld, Marit, et al.
Publicado: (2021)

The Automatic External Cardioverter-Defibrillator
por: Martínez-Rubio, Antoni, et al.
Publicado: (2004)

Deactivation of implantable cardioverter-defibrillators
por: Wan, Darryl, et al.
Publicado: (2021)

Predictors of appropriate therapy in patients with implantable cardioverter-defibrillator for primary prevention of sudden cardiac death
por: Ahmed, Imdad, et al.
Publicado: (2010)

Impact of Moderate to Severe Renal Impairment on Mortality and Appropriate Shocks in Patients with Implantable Cardioverter Defibrillators
por: Alla, Venkata M., et al.
Publicado: (2010)

Appropriate and Inappropriate Implantable Cardioverter Defibrillators Therapies in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia Patients
por: Al-Ghamdi, Bandar, et al.
Publicado: (2018)

Factors associated with implantable cardioverter defibrillators appropriate therapy in cardiac sarcoidosis: a meta-analysis
por: Azoulay, Levi-Dan, et al.
Publicado: (2020)

The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)

Implantable cardioverter defibrillator implantation and degree of left ventricular scarring predict survival in patients with severe ischemic cardiomyopathy
por: Kwon, Deboarh H, et al.
Publicado: (2011)

Sex difference in appropriate shocks but not mortality during long-term follow-up in patients with implantable cardioverter-defibrillators
por: Seegers, Joachim, et al.
Publicado: (2016)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
por: Jazayeri, Mohammad-Ali, et al.
Publicado: (2017)

Long‐term follow‐up of implantable cardioverter defibrillator patients with regard to appropriate therapy, complications, and mortality
por: Mattsson, Gustav, et al.
Publicado: (2020)

Association of Night-Time Heart Rate With Ventricular Tachyarrhythmias, Appropriate and Inappropriate Implantable Cardioverter-Defibrillator Shocks
por: Sun, Xuerong, et al.
Publicado: (2021)

Management of implantable cardioverter-defibrillator patients with appropriate ICD shocks: A 3-step treatment concept
por: Kleemann, Thomas, et al.
Publicado: (2021)

Defibrillation Testing of the Implantable Cardioverter Defibrillator: When, How, and by Whom?
por: Pires, Luis A
Publicado: (2007)

Predictors of Elevated Defibrillation Threshold with the Subcutaneous Implantable Cardioverter-defibrillator
por: Do, Khuyen, et al.
Publicado: (2017)

Improvements in 25 Years of Implantable Cardioverter Defibrillator Therapy
por: van Welsenes, G. H., et al.
Publicado: (2010)

Relationship of ostial pulmonary vein scar with reduction in pulmonary vein size after atrial fibrillation ablation
por: Hauser, Thomas H, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_io7q4cqgh0rimn0l34fh071f2l